Trade AstraZeneca ^AZN

AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?

Assenagon Asset Management S.A. Buys 422,866 Shares of Astrazeneca Plc $AZN - Markets Daily

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN | Morningstar

AI-based augmentation of oncology clinical trials

The dynamic spectrum of steatotic liver disease: the global perspective

Artificial intelligence in drug discovery - what it is, where we stand and the path forward

North American Morning Briefing: Nasdaq Futures Slip on AI Anxiety | Morningstar

Tlwm Makes New $1.76 Million Investment in Astrazeneca Plc $AZN

AstraZeneca may buck a decade of pharma strategy to buy U.S. scale

180 Wealth Advisors LLC Invests $3.89 Million in Astrazeneca Plc $AZN

High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?

AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma

AstraZeneca, Jaguar Land Rover join UK push to lure talent away from US

AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group - Daily Political

Astrazeneca (NYSE:AZN) Sees Large Volume Increase - Here's What Happened

SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - Markets Daily

SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 1-Year High After Analyst Upgrade - Zolmax

AstraZeneca and Bristol Myers Squibb merger talks denied

Astrazeneca Plc (NYSE:AZN) Plans Dividend of GBP 0.80

Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - Zolmax

Deutsche Bank Aktiengesellschaft Reiterates Sell Rating for AstraZeneca (LON:AZN) - Daily Political

Harvard Student Consultants Log 400 Hours and Party With Snakes

Astrazeneca Plc (AZN) to Issue Dividend of GBP 0.80 on September 8th - Daily Political

SOPHiA GENETICS (NASDAQ:SOPH) Price Target Raised to $9.00 at BTIG Research - Daily Political

Eastern Bank Purchases Shares of 6,092 Astrazeneca Plc $AZN - Daily Political

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group

AstraZeneca-BMY megadeal talk sparks huge market rift

SOPH Stock Heads For Best Day In Over 8 Months - What's Driving Today's Super Rally?

Brokers split on AstraZeneca merger talk as shares recover some ground

Most big businesses bought zero new petrol or diesel cars for their fleets last year, report reveals

SOPHiA GENETICS Collaborates With AstraZeneca To Develop Precision Oncology Companion Diagnostics

Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN

Pharmaceutical Stocks Worth Watching - August 4th - Daily Political

Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer

Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?

UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn

Navigating evidence-based recommendations for the management of systemic sclerosis

International Business: AstraZeneca shares fall on merger talks

Advances in the treatment of eosinophilic granulomatosis with polyangiitis

European shares start August higher on US-Iran diplomacy hopes

Amazon joins US$3t market cap club as cheaper oil buoys market

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks

Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could "Cut Costs in a Big Way"

Astrazeneca (NYSE:AZN) Shares Gap Down - Should You Sell? - Markets Daily

Stocks mixed as AstraZeneca merger talk dents FTSE 100

AstraZeneca shares slump after $400bn BMS merger rumours

Investors Buy Large Volume of Call Options on Astrazeneca (NYSE:AZN)

AstraZeneca Slides 8% On Report Of Potential Bristol Myers Merger Talks

AstraZeneca and Bristol-Myers Squibb: Megamerger Reports Leave Us Scratching Our Heads | Morningstar

AstraZeneca (LON:AZN) Stock Price Down 9% - Time to Sell? - Stock Observer

Execs hail 'merger of equals' in Supernus, Indivior deal

AstraZeneca Down Nearly 8%, on Pace for Largest Percent Decrease Since April 2025 - Data Talk | Morningstar

Compugen Q2 Earnings Call Highlights - Zolmax

Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca

Manufacturing Stocks To Add to Your Watchlist - August 3rd - Stock Observer

An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it 'odd' | Morningstar

Astrazeneca (NYSE:AZN) Shares Gap Down - Here's Why - Stock Observer

A $400 Billion Pharma Deal Could Get Really Messy: Chris Hughes

An AstraZeneca-Bristol Myers megamerger? Wall Street isn't thrilled.

AstraZeneca Weighs a Deal Its CEO Said It Didn't Need

Report: AstraZeneca explores tie-up with Bristol Myers Squibb

Dow Jones Top Company Headlines at 7 AM ET: AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports | Banco ... | Morningstar

AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. | Morningstar

AstraZeneca Investors See Little Logic in Bristol-Myers Tie-Up

AstraZeneca shares sink 7% on report of historic $400 billion merger talks with Bristol Myers Squibb

North American Morning Briefing: Stock Futures Up, Oil Slumps After Trump Calls Off Iran Attack | Morningstar

AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports - Update | Morningstar

Rathbones Group PLC Has $1.56 Billion Stock Holdings in Astrazeneca Plc $AZN - Markets Daily

European Midday Briefing: Shares Rise, Oil Tumbles on Renewed U.S.-Iran Diplomacy | Morningstar

AstraZeneca Shares Sink 7% As Bristol Myers Merger Talks Spark...

AstraZeneca shares drop on reports of $570b mega-merger

| Country News

AstraZeneca Shares Drop After Reports of Bristol Myers Squibb Merger Talks | Morningstar

Bristol Myers Squibb (BMY) In Early Merger Talks With AstraZeneca

AstraZeneca shares tumble 7% after reported Bristol Myers talks

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

AstraZeneca in talks over £300bn mega-merger with US rival - reports

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources | Morningstar

AstraZeneca and Bristol Myers Squibb Explore $400 Billion Merger Talks, ETPharma

AstraZeneca And Bristol Myers Reportedly In Talks On $400 Bln Deal

Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure?

Astrazeneca Plc (NYSE:AZN) Given Consensus Rating of "Moderate Buy" by Analysts - Daily Political

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

The next generation of antibody-drug conjugates

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca holds talks with Bristol Myers Squibb on US$400 billion megadeal

AstraZeneca held talks with Bristol Myers Squibb on US$400 billion megadeal: source

AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report

AstraZeneca and Bristol-Myers Squibb in talks over potential merger - Report

AstraZeneca plots £300bn tie-up with US rival

AstraZeneca holds talks with Bristol Myers Squibb on potential megadeal, report says

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports